138 related articles for article (PubMed ID: 32072904)
1. Anti-tumorigenic Efficacy of Tangeretin in Liver Cancer - An In Silico Approach.
P S; K L
Curr Comput Aided Drug Des; 2021; 17(3):337-343. PubMed ID: 32072904
[TBL] [Abstract][Full Text] [Related]
2. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells.
Chen KH; Weng MS; Lin JK
Biochem Pharmacol; 2007 Jan; 73(2):215-27. PubMed ID: 17067555
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology predicted HDAC6 as a potential target of flavones from
Chen JJ; Shang XY; Han FY; Zhang Y; Zhao D; Yao GD; Song SJ
Nat Prod Res; 2021 Sep; 35(18):3171-3175. PubMed ID: 31741408
[No Abstract] [Full Text] [Related]
4. Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats.
Lakshmi A; Subramanian S
Biochimie; 2014 Apr; 99():96-109. PubMed ID: 24299963
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer?
Breinig M; Schirmacher P; Kern MA
Curr Pharm Des; 2007; 13(32):3305-15. PubMed ID: 18045183
[TBL] [Abstract][Full Text] [Related]
6. Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells.
Lin JJ; Huang CC; Su YL; Luo HL; Lee NL; Sung MT; Wu YJ
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30813616
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and dynamic simulations of
Sangeetha R; Arockia Jeya Yasmi Prabha E; Lakshmi A; Sangavi P; Langeswaran K
J Biomol Struct Dyn; 2022; 40(24):13997-14012. PubMed ID: 34738880
[TBL] [Abstract][Full Text] [Related]
8. In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug.
Shi XN; Li H; Yao H; Liu X; Li L; Leung KS; Kung HF; Lu D; Wong MH; Lin MC
PLoS One; 2015; 10(7):e0132072. PubMed ID: 26147897
[TBL] [Abstract][Full Text] [Related]
9. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells.
Shu Z; Yang B; Zhao H; Xu B; Jiao W; Wang Q; Wang Z; Kuang H
Int Immunopharmacol; 2014 Apr; 19(2):275-82. PubMed ID: 24462494
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacological evaluation of strigolactones efficacy as potential inhibitors against therapeutic targets of hepatocellular carcinoma.
Amod A; Pahal S; Choudhary P; Gupta A; Singh S
Biotechnol Lett; 2022 Jul; 44(7):879-900. PubMed ID: 35672528
[TBL] [Abstract][Full Text] [Related]
11. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
Feng SL; Yuan ZW; Yao XJ; Ma WZ; Liu L; Liu ZQ; Xie Y
Pharmacol Res; 2016 Aug; 110():193-204. PubMed ID: 27058921
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of escitalopram oxalate and related antidepressants as putative inhibitors of PTP4A3/PRL-3 protein in hepatocellular carcinoma: A multi-computational investigation.
Mir IH; Shyam KT; Balakrishnan SS; Kumar MS; Ramesh T; Thirunavukkarasu C
Comput Biol Chem; 2024 Jun; 110():108039. PubMed ID: 38471352
[TBL] [Abstract][Full Text] [Related]
13. Tangeretin reduces ultraviolet B (UVB)-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking mitogen-activated protein kinase (MAPK) activation and reactive oxygen species (ROS) generation.
Yoon JH; Lim TG; Lee KM; Jeon AJ; Kim SY; Lee KW
J Agric Food Chem; 2011 Jan; 59(1):222-8. PubMed ID: 21126077
[TBL] [Abstract][Full Text] [Related]
14. Computational assessment of chemicals from
Ugwah-Oguejiofor CJ; Chukwuka EP; Onifade OF; Agu ST; Adegboyega AE; Johnson GI; Ogunsuyi OI; Johnson TO
J Biomol Struct Dyn; 2023; 41(22):13271-13286. PubMed ID: 36709454
[TBL] [Abstract][Full Text] [Related]
15. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
16.
Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
[TBL] [Abstract][Full Text] [Related]
17. Acteoside (Verbascoside): A Prospective Therapeutic Alternative against Hepatocellular Carcinoma by Inhibiting the Expression of AXL, FGFR, BRAF, TIE2 and RAF1 Targets.
Kityania S; Nath R; Nath D; Patra JK; Talukdar AD
Comb Chem High Throughput Screen; 2023; 26(10):1907-1919. PubMed ID: 36321230
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
19. Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinoma.
Arivazhagan L; Sorimuthu Pillai S
J Nutr Biochem; 2014 Nov; 25(11):1140-1153. PubMed ID: 25151216
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin.
Kurowska EM; Manthey JA; Casaschi A; Theriault AG
Lipids; 2004 Feb; 39(2):143-51. PubMed ID: 15134141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
